Next generation RNA sequencing elucidates the antitumor effects of Zelnorm via immune microenvironment regulation. Next generation RNA sequencing elucidates the antitumor effects of Zelnorm via immune microenvironment regulation
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
Syngeneic B16F10 tumors were subcutaneously established in female C57BL/6J mice. Zelnorm (1.25 mg/kg) were orally administrated once every two days. Tumor volume and body weight were assessed (tumor volume=1/2 (length×width2)). Tumors were excised and weighted. Tumor samples were profiled by RNA-seq analysis. Overall design: control group (NC), Zelnorm group (MBZ)
创建时间：
2022-03-16
